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Available online xxxxCardiac electrophysiologymodels have been developed for over 50 years, and now include detailed descriptions
of individual ion currents and sub-cellular calcium handling. It is commonly accepted that there are many
uncertainties in these systems, with quantities such as ion channel kinetics or expression levels being difﬁcult
to measure or variable between samples. Until recently, the original approach of describing model parameters
using single values has been retained, and consequently the majority of mathematical models in use today
provide point predictions, with no associated uncertainty.
In recent years, statistical techniques have been developed and applied inmany scientiﬁc areas to capture uncer-
tainties in the quantities that determine model behaviour, and to provide a distribution of predictions which
accounts for this uncertainty. In this paper we discuss this concept, which is termed uncertainty quantiﬁcation,
and consider how it might be applied to cardiac electrophysiology models.
We present two case studies in which probability distributions, instead of individual numbers, are inferred from
data to describe quantities such as maximal current densities. Then we show how these probabilistic represen-
tations of model parameters enable probabilities to be placed on predicted behaviours. We demonstrate how
changes in these probability distributions across data sets offer insight into which currents cause beat-to-beat
variability in canine APs. We conclude with a discussion of the challenges that this approach entails, and how
it provides opportunities to improve our understanding of electrophysiology.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
Uncertainty quantiﬁcation
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Mathematical model
Probability1. Introduction
Models of the cardiac action potential (AP) are established, valuable,
and important research tools because they integrate biophysical mecha-
nisms quantitatively, and so have explanatory and predictive power.
Since the publication of the ﬁrst cardiac AP model over 50 years ago
[31] these models have become more detailed as our knowledge of the
function of ion channels, pumps, and exchangers in cardiac myocytes
has increased [11]. Contemporary models are sufﬁciently detailed toCMA–ES, Covariance Matrix
MCMC, Markov Chain Monte
cher et al. (2006) [45] action po-
ns-membrane Voltage; VVUQ,
Pathmanathan),
s.ox.ac.uk (G.R. Mirams).
. This is an open access article under
al., Uncertainty and variabilit
.doi.org/10.1016/j.yjmcc.2015allow the effects of ion channel gene mutations, pharmaceuticals, and
disease to be examined in mechanistic detail [41], [28]. However, while
the present generation of models are powerful tools, model parameters
are generally assigned a ﬁxed value, which means that the models pro-
duce a ﬁxed prediction.
In contrast, the experimental APs recorded from real cardiac cells are
variable, with changes from beat-to-beat in a single cell (termed intrin-
sic variability), and from one cell to another (extrinsic variability).
Intrinsic variability may be caused by random processes such as sto-
chastic ion channel gating, non-linear dynamics such as alternans of ac-
tion potential duration (APD), or more complex behaviour. Extrinsic
variability is considered to be caused by quantities that genuinely vary
from cell to cell, e.g. cell size or ion channel expression. In practice it
can be difﬁcult to distinguish these sources of variability; in what fol-
lows we model variability as extrinsic only, although some of our data
may also capture intrinsic variability. In addition, variability can be
compounded by measurement errors when data from experiments
are used to generate parameters for use in AP models.the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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diac electrophysiology, and new approaches are beginning to emerge
from areas as diverse as models of the atmosphere [24] and galaxy for-
mation [47]. In this paper we describe how these approaches might be
applied to cardiac AP models.
1.1. Uncertainty quantiﬁcation and cardiac action potential models
There are several potential sources of uncertainty in a computational
model of a real system; these include, at least, the following [47]:
• Observational uncertainty is uncertainty or measurement errors in ex-
perimental data. For example, uncertainty represented by error bars
in measurements of the current–voltage proﬁle for a particular ion
channel used to assign model parameters, or error bars in measure-
ments of APD restitution used to evaluate model performance. Note
that this uncertainty can encapsulate both intrinsic and extrinsic vari-
ability.
• Parameter uncertainty refers to uncertainty in model parameters,
which may be a consequence of observational uncertainty as well as
variability, or simply lack of information. It may be advantageous to
express a model parameter (such as a maximal conductance) as a
random variable with a distribution, rather than a ﬁxed value.
• Condition uncertainty describes our uncertainty about the initial condi-
tions and boundary conditions. For a cardiac AP model the initial con-
ditions are typically set by running the model until it has reached a
steady state, but this will not capture the constantly varying environ-
ment of temperature, ion concentrations, and metabolism in which a
real cell operates.
• Structural uncertainty accounts for the differences between a model
and the real system that it represents. For example, a model of an ion
channel will not be an exact representation of the biophysical dynam-
ics of a population of proteins in the membrane, and structural uncer-
tainty aims to quantify this difference.
• Simulator uncertainty addresses the uncertainty introduced when
using an approximation to the true solution of the equations of
the mathematical model when we perform a simulation. This in-
cludes any uncertainty introduced by using discretisation in nu-
merical methods (numerical error), or uncertainty when a fast-
running surrogate model (e.g. an emulator) is used approximate
the outputs of a computational model that is expensive to solve.
Techniques for uncertainty quantiﬁcation (UQ) provide a means to
deal with these different sources of uncertainty. In this paper we con-
centrate on UQ methods that address parameter and condition uncer-
tainty, which will also concern observation and simulator uncertainty.
Statistical methods for structural uncertainty can be complex and are
outside the scope of this paper. Such techniques attempt to statistically
quantify the ‘model bias’, the difference between model and experi-
ment; the interested reader may refer to [22].
There are two stages toUQ related to parameter/conditionuncertainty
(for claritywe only refer to parameters below, but the same ideas apply to
initial or boundary conditions, though these may be more difﬁcult to
measure):
1. Uncertainty characterisation regards uncertainty in model inputs. In
this stage uncertainty in parameters is characterised by assigning
probability distributions to input parameters instead of single values,
although sometimes simple statistics (i.e. means and variances) are
used. If the input is a parameter that is directly measurable, this is a
purely experimental task because the probability distribution is in-
formed by the experimental observations. On the other hand, if the
input is a parameter that is indirectly inferred from other data, statis-
tical methodsmay be required to estimate the parameter uncertainty
(examples will be provided in this paper).
2. Uncertainty propagation (or uncertainty analysis) regards uncertainty
in model outputs. Here the aim is to establish the uncertainty inPlease cite this article as: R.H. Johnstone, et al., Uncertainty and variabilit
models?, J Mol Cell Cardiol (2015), http://dx.doi.org/10.1016/j.yjmcc.2015model outputs due to the uncertainty in inputs, again as probability
distributions or simple statistics. Generally, this stage is very
computationally-demanding, since a large number of simulations
are needed to generate outputs for the different combinations of in-
puts that are possible. Sophisticated methods have been developed
to mitigate such difﬁculties, as will be illustrated in this paper
Interest in UQ has grown as part of a drive for rigorous and formal
approaches to assess the credibility of computational models. The
heavy use of computational models for safety-critical applications in
the automotive, aerospace, nuclear and structural engineering indus-
tries in particularmotivated thedevelopment of ‘Veriﬁcation, Validation
and Uncertainty Quantiﬁcation’ (VVUQ), which forms a set of method-
ologies, frameworks and best practises for improved assessment of the
reliability and robustness ofmodel predictions [30], [33]. In this context,
veriﬁcation is deﬁned as the process of conﬁrming that a computational
model (software) correctly implements an underlying mathematical
model, and validation compares a model's predictions with reality. Al-
though UQ forms part of the overall VVUQ process, each of the stages
are intertwined, and in particular UQ improves the ability to perform
validation, since understanding the uncertainty inmodel predictions fa-
cilitates comparison with experimental results.
Until recently, VVUQ has not been a priority for cardiac modelling,
because this type of model has not been widely used in high-risk or
safety-critical applications. However, the present generation of cardiac
AP models are sufﬁciently detailed that there is the prospect that they
could be used as both as part of clinical applications and also for drug
safety assessment. Both of these applications are safety critical. For clin-
ical applications themodel output could be guidance for ablation in clin-
ical procedures, and the inputs would include personalised measures of
tissue conductivity and anatomy [46]. For safety testing in drug devel-
opment, the output could be ameasure of action potential prolongation,
and the inputs would include a quantiﬁcation of the reduction of differ-
ent ion currents as a function of compound concentration [27]. In both
types of application it will be important to express a measure of conﬁ-
dence in themodel outputs, given uncertainties and errors in the inputs.
As a result, there has been growing interest and application of (VV)UQ
in cardiac modelling [14], [10], [36], [37], [38].
In [38] Pathmanathan et al. quantiﬁed the natural variability in the
steady-state inactivation of the canine fast sodium channel using a sta-
tistical framework known as Non-Linear Mixed Effects (NLME) model-
ling. The authors examined the consequences of this uncertainty at
the cellular and tissue scales, in perhaps the ﬁrst application of uncer-
tainty quantiﬁcation to multi-scale cardiac modelling. In Fig. 1 we pres-
ent a summary of this study, as it provides an excellent introduction to
the concept of uncertainty quantiﬁcation applied to this ﬁeld.
We have also included a short extension to this work in Supplemen-
tary Material A, where we examine how the same technique can be ap-
plied to investigate both intra- and inter-animal variability in cellular
recordings.
1.2. Aim and scope
The pipeline shown in Fig. 1 concentrates on a single component of
INa channel behaviour, and examines how observation uncertainty can
be expressed as parameter uncertainty, and how UQ can be used to es-
tablish how these uncertainties inﬂuence the model output.
The aim of this paper is apply a statistical UQ approach to cardiac AP
models, and so gain mechanistic insight into the models as well as car-
diacmyocytes.We present two complementary case studies. In the ﬁrst
case studywe showhow themaximal conductances of ion channels can
be inferred from noisy experimental recordings as distributions that ex-
press uncertainty about the estimates. The second case study then uses
a statistical model (an emulator, surrogate model or metamodel) of a
cardiac APmodel to examine how uncertainties inmaximal ion channel
conductances inﬂuence uncertainty in model outputs, such as APD.y in models of the cardiac action potential: Can we build trustworthy
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voltage recordings
Some of the most important parameters in determining APmodel
behaviour are the maximal densities of each ion current, which
represent the number of each type of ion transporter in the cell
membrane. In what follows we will use the terminology ‘conduc-
tances’ as shorthand to refer to the maximal densities of currents
ﬂowing through ion channels and also pumps and exchangers. In
this case study we infer conductances for AP models from voltage
vs. time data traces.
We expected that (i) the complexity of the model, and (ii) the rich-
ness of the experiment would determine the conductances that were
constrained by data. For example, for a simple model with a small num-
ber (≤6) of ion currents, we might expect that only a certain combina-
tion of conductance values produces the observed AP, and therefore
we can infer all of them. For amore complicatedmodelwith tens of con-
ductances, there may be many options for ‘balancing the currents’ to
give the same AP, and so we would not be able to establish unique esti-
mates for each conductance. Similarly, a simple experiment such as a
single AP recording may contain less information than a more complex
protocol with, for instance, multiple pacing frequencies.
A similar approachwas taken recently to estimate single ion channel
kinetics [43], [42]. We consider a probabilistic method, and our overall
aim is to compute the probability of any set of conductances (which
we denote θ) given the observed data, or p(θ |data).
There are a number of experimentally plausible protocols that can be
used to generate AP data, including steady pacing at different rates,
changing ion concentrations of the extracellular solution, or applying a
pharmaceutical intervention to block a speciﬁc ion current. We repeat-
ed the following study with a range of mathematical AP models, and aFig. 1. Pipeline of the UQ process, applied to variability in steady-state INa inactivation (image
myocytes (sub-ﬁgure (a), individual cells in grey, averaged data in black, note how the slope o
variability was characterised by ﬁtting a two-parameter sigmoidal curve using the statistical me
(b) illustrates themean (red star) and variability (red ellipse: 95%; grey ellipses: 80% and 99%) o
responds to an ‘average’ cell, not the averaged data. This inactivation sub-modelwas then embe
through themodel to obtain a probability distribution for upstroke velocity (subﬁgure (c)). How
population variability (subﬁgure (d)).
Please cite this article as: R.H. Johnstone, et al., Uncertainty and variabilit
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ductances that we can infer.
2.1. Methods
This case study was performed ﬁrstly on synthetic data, generated
from a range of AP models, and then secondly on experimental canine
action potential recordings.
2.1.1. Synthetic data
We used noisy simulated data as our voltage recordings, which pro-
vide a best-case scenario of the recordings we would observe if the AP
model was ‘correct’ (eliminating the need to consider structural uncer-
tainty).We refer to these simulated traceswith addednoise as synthetic
data. Synthetic datawere generated by solving equations for a particular
AP model, given one of our experimental protocols, with the conduc-
tances that feature in the published model. We sampled the simulation
output at 0.2ms intervals and then added randomnoise to each point of
this synthetic voltage trace to simulate any noise in the system or the
observations. The noisewas randomly sampled from a Normal distribu-
tion with mean zero and standard deviation of σ=0.25 mV, chosen as
this described the noise at resting potential on a repolarised canine
ventricular AP experimental recording (as described below). We then
‘forgot’ the conductances that were used (θ^), and the noise parameter
σ, and attempted to solve an inverse problem to infer these from just
the synthetic data trace.
2.1.2. Experimental data
Canine cardiomyocytes were isolated as described previously
[29]. A drop of cell suspension was placed in a recording chamber,adapted from [38]). Using experimental data on steady-state INa inactivation from canine
f the average does not match the slope of any individual), uncertainty due to population
thod nonlinear mixed effects to estimate the variability in the two parameters. Sub-ﬁgure
f the two parameters (blue stars represent parameters for individual cells). Themean cor-
dded in the Fox et al. [12] canine APmodel, and the parameter uncertaintywas propagated
ever, themodel did not repolarise for a region of parameter space that overlappedwith the
y in models of the cardiac action potential: Can we build trustworthy
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normal modiﬁed Tyrode's solution was started. Cardiomyocytes
were patched with patch pipettes with a resistance of 3–4 MΩ, and
action potentials were recorded in whole-cell conﬁguration. After
obtaining access and adjusting series resistance compensation
(N70%), continuous 1 Hz pacing with a 3 nA, 2 ms stimulus was
started. Time resolution of the recordings was 250 μs (4 kHz),
while voltage resolution was 31.2 μV. Recordings in the dataset
(available to download with the simulation code) cover ≈ 800 ms
of each pace, when the action potential occurs, in order to give pro-
cessing time to log these data continuously.
The bath solution was composed of (concentrations in mM) NaCl
130, KCl 4, CaCl2 1.8, MgCl2 1.2, NaHCO3 18, HEPES 10 and glucose 10,
and pH was set at 7.4 with NaOH. Pipettes were ﬁlled with (in mM)
NaCl 10, KCl 130, MgCl2 0.5, HEPES 10, MgATP 5, and pH was set at 7.2
with KOH. After 200 s of pacing 10 μM of Moxiﬂoxacin was introduced
to the bath, and at 240 s the bath concentration of KCl was increased
to 5.4 mM.
The APD of each experimental pace is shown in Supplementary
Material Figure B2, along with an indication of the paces that were
selected as approximately steady-state for training and validation
purposes.
We chose to use the Davies et al. canine model [9] (a modiﬁed
version of the Hund & Rudy model [20]) for ﬁtting to these data, as
its default parameters resulted in a 1 Hz action potential that
displayed similar features to those observed in our experiments. To
model the effect of adding 5.4 mM KCl we changed the extracellular
K+ in the model from 4mM at control/training to 5.4 mM for predic-
tions/validation. The action of 10 μM Moxiﬂoxacin was modelled as
conductance block with IC50 values of: 29 μM for IKr [1]; 206.7 μM
for INa [17]; and 158 μM for IKs and ICaL (both have pIC50 values of
3.8 in [27]). Further details on the methods, including treatment of
the stimulus, can be found in Supplementary Material B5.
2.1.3. Bayesian inference
Because all data are inherently noisy to some degree, it does not
make sense to say that a model prediction ‘matches’ data, instead we
wish to say ‘how close a match’ there is to data. Using a probabilistic
framework we can assign a goodness-of-ﬁt score called the likelihood
to any set of conductances: the probability of the observed data arising
if the conductances were the true values, i.e. p(data|θ). Details of the
mathematical deﬁnition of the likelihood and assumptions involved
are provided in Supplementary Material B2; below we provide a brief
summary.
To deﬁne the likelihood we need a statistical model for the noise as-
sociated with the recording. Here we used a simple framework given
by:
Observed data ¼ System behaviourþ Noise model: ð1Þ
Differences between simulated voltage trace and the observed (syn-
thetic or experimental) data trace are then assumed to be due to noise,
which we assumed to follow a Normal distribution withmean zero and
an unknown standard deviation σ. (While σ=0.25 mV was used to
generate the synthetic data, in general this would not be known, and
so we attempted to infer σ alongside the conductances.) The likelihood
is computed by solving the model equations with some proposed
parameter values and comparing the resulting voltage trace with the
synthetic data trace. Assuming themeasurements in the trace are inde-
pendent, the total likelihood is the product of the likelihood of each
point in the trace.22 Since likelihoods are often the product of very small numbers, we generally compute
the logarithm of the likelihood, which is less prone to numerical error, and for a Normal
distribution simpliﬁes the calculation. The log-likelihood can be positive or negative; a
larger log-likelihood in the positive direction indicates a better ﬁt.
Please cite this article as: R.H. Johnstone, et al., Uncertainty and variabilit
models?, J Mol Cell Cardiol (2015), http://dx.doi.org/10.1016/j.yjmcc.2015Once the modelling phase has led to an expression for p(data |θ),
inference determines the probability of a parameter set given the
data, p(θ | data), also commonly denoted as π(θ). Bayes' Theorem
yields.
π θð Þ ¼ p datajθð Þp θð ÞZ
p datajθð Þp θð Þdθ ; ð2Þ
where p(θ) is a probability distribution containing our prior knowledge
and assumptions about the parameters, and the integral is over the
whole range of possible parameter sets. We refer the interested reader
to a good textbook introduction [39].
In this case,we supposed thatwe had very little prior information on
the parameter values, and took a uniform prior over intervals ranging
from0.1× to 10× the originalmodel value (i.e. p(θ) is equal to a positive
constant within these intervals and zero otherwise). Note that current–
voltage (IV) curvesmay providemore useful prior information for some
ion currents where available.
Withmany parameters, we cannot directly compute π(θ), and sowe
use Markov Chain Monte Carlo (MCMC, [40]) methods, which only re-
quire being able to evaluate p(data |θ) at any given parameter set θ.
MCMC methods output a sequence/chain of parameter sets that form
approximate independent samples from our target probability distribu-
tion π(θ). For a more detailed description of the MCMC algorithm that
we used, see Supplementary Material B.
As it approximates samples from π(θ), MCMC will spend time in
regions of large likelihood, so we start MCMC from a point with a rea-
sonably large likelihood. To this end, we ﬁrst ran a minimisation al-
gorithm on the negative likelihood. Here, we used a minimisation
algorithm called Covariance Matrix Adaptation–Evolution Strategy
(CMA–ES, [16]). CMA–ES was started from a random point within
the prior intervals deﬁning p(θ). This resulted in the point(s) with
the best log-likelihood. We could then use one of these points as a
starting point, and subsequently checked that MCMC visited the
neighbourhood of all these points regularly, since approximately
sampling from π(θ) requires sampling from all regions where π(θ)
is large and smooth.
Fig. 2 shows the likelihood of the parameter set during a CMA–ES
run (mean likelihood given), followed by each MCMC iteration. Sets of
parameters at three different points have been selected and their corre-
sponding AP traces plotted over the experimental trace, to show the
convergence of the minimisation and subsequent local search by
MCMC.
After running the MCMC, we discarded the ﬁrst quarter of all
MCMC iterations as a burn-in period, during which we expect the
chain to be settling into the target probability distribution. We also
thinned the chain by only saving every tenth iteration. Practically,
this reduces the output ﬁle size, and theoretically, it can help the
chain better represent independent samples from the target distribu-
tion. The remaining samples form a distribution across parameters
that approximates the probability distribution of conductances
given the synthetic data.
All of the simulationswere performed using the Chaste C++ library
[26], [8]. The code we wrote for this is openly available, as described in
Supplementary Material B1.
2.2. Results
2.2.1. Synthetic Data
In this section we examine howmuch information on individual ion
current conductances is present in synthetic data from a range of proto-
cols, in terms of the certainty we gain in possible conductance values
after performing the inference described above.
The ﬁrst experimental protocol we tested was 1 Hz pacing, recording
the membrane voltage for sufﬁciently long to capture a single AP (asy in models of the cardiac action potential: Can we build trustworthy
.11.018
Fig. 2. Top: synthetic data example ofminimisation andMCMC for the Luo& Rudymodel [25]:minimisation of the negative log-likelihood to ﬁnd starting point forMCMC followed by log-
likelihoods obtained during MCMC. The MCMC begins at the vertical red line, note the log scale on the x-axis —minimisation is a much smaller proportion of the iterations than MCMC.
Points A, B and C are at iterations 8, 100 and 2000, respectively. Inset is a zoomed in view of the highlighted box, showing the MCMC exploring the likelihood between iterations 2000 and
3000. Panels A–C: the blue traces are the APs for the proposed parameters at iterations marked as A, B and C. Red traces are the same synthetic data in all 3 plots. Panels D–F: three exper-
imentally recorded canine APs are shown in red in panels D, E and F. The green trace is the Davies et al. 1 Hz steady pacing AP [9], and the blue trace is the same model with conductances
inferred to ﬁt the experimental recordings.
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showing parameter distributions that were inferred for the Beeler &
Reuter (1977) model [3]. In this plot the main diagonal contains histo-
grams of the values each parameter takes through the MCMC run, and
the off-diagonal entries contain heat maps showing the proportion of
the run spent in that area for each pair of parameters. Also plotted
are: the original parameter values, as vertical and horizontal green
lines across the plots; and 95% credible intervals for each parameter as
vertical red lines on the histograms (the intervals within which 95% of
the values lie — constructed by ‘discarding’ the outermost 2.5% of the
samples from the histogram, on each side).
In Fig. 3 all of the probability distributions are very narrow, in that
the credible intervals (red lines) are very close, in absolute terms, to
the original parameter values (green lines). We conclude that all 4 con-
ductance parameters are successfully inferred from a single AP trace,
and the noise parameter σ has also been inferred well.
To quantify this, we require a measure of how successful the infer-
ence process has been for any model and protocol.
For each parameter θi, we deﬁne its mean absolute percentage error
(Mi) across the MCMC run (excluding the burn-in period) as:
Mi ¼
1
N
∑
t¼1
N θ^i−θt;i
θ^i

; ð3ÞPlease cite this article as: R.H. Johnstone, et al., Uncertainty and variabilit
models?, J Mol Cell Cardiol (2015), http://dx.doi.org/10.1016/j.yjmcc.2015where θ ̂i is the actual value of the parameter, i.e. the value used when
creating the synthetic data, θt ,i is the value of parameter i at iteration t
of the MCMC run, and N is the total number of iterations in the MCMC
run. We say we have successfully inferred a parameter if Mib0.05 (on
average the parameter value in the chain is within 5% of the actual
value of the parameter).
A summary of the number of maximal conductance parameters suc-
cessfully inferred for eachmodel under the protocols is given in Table 1.
The noise parameter σ is always successfully inferred, and therefore
omitted from the table. A more detailed table of which conductance
parameters were successfully inferred from the models ([44], [34] &
[9]) is given in Table B1 in Supplementary Material B.
For the simple models [3,19,25,31] (with ≤6 conductance parame-
ters), a single 1 Hz AP provides enough information for us to successfully
infer all conductance parameters. However, a single AP did not provide
enough information for us to successfully infer all parameters from the
more complex models. For example, Fig. 4 shows a subset of the scatter
plot array from the ten Tusscher et al. (2004) model [44]. Here, GNa is in-
ferred successfully, and we see narrow histograms this parameter. How-
ever, the background currents GbCa andGbNa are not successfully inferred,
and their histograms extend to the edge of the prior rangewe considered
(0.1× the original value). There is also a strong interdependence between
the two parameters visible in their pairwise plot; it seems that a high
value for GbCa and low value for GbNa ﬁt the data just as well as a low
value for GbCa and high value for GbNa. This dependence is an indicationy in models of the cardiac action potential: Can we build trustworthy
.11.018
Fig. 3.Marginal and 2-d normalised histograms representing marginal and pairwise probability distributions of each parameter, using the Beeler & Reuter model [3] model and single AP
protocol. All parameters have been successfully inferred from the data (seemain text). The vertical red (outside) lines give the 95% credible interval. The vertical green (inside) line is the
parameter value used to generate the synthetic data.
6 R.H. Johnstone et al. / Journal of Molecular and Cellular Cardiology xxx (2015) xxx–xxxthat there is unidentiﬁability of parameters—multiple parameter sets ﬁt
the data equally well, and the individual conductances cannot be identi-
ﬁed (using this protocol). PNaK appears to have formed a well-deﬁned
distribution, but it is too wide to meet our criterion of success.
Other protocols shown in Table 1 include halving and doubling the
extracellular potassium concentration, [K+]o, when measuring a single
AP. The latter reduced the number of conductance parameters we
could infer in the more complex models. In particular, using the ten
Tusscher et al. [44] model and doubling [K+]o, the histograms for GK1,
GKr, and GKs are shifted to lower values (shown in SupplementaryMate-
rial Figure B4). As such, the values moved away from the true parame-
ters and so their Mi values increased. In an attempt to obtain a more
informative voltage trace, we investigated longer and more complex
protocols. We used an S1–S2 pacing protocol, 1 Hz followed by 2 Hz,
and measured for a total of 2000 ms, giving a trace with three APs. In
the case of the two most complex models, this increased the overall
number of successfully inferred conductances, presumably as differentPlease cite this article as: R.H. Johnstone, et al., Uncertainty and variabilit
models?, J Mol Cell Cardiol (2015), http://dx.doi.org/10.1016/j.yjmcc.2015currents give different contributions at the two rates, but we still
could not infer all conductances.
We then tested a series of protocols in which we simulated the
effects of pharmaceutical block of particular ion currents. With a 1 Hz
pacing rate, we measured for a total of 2000 ms and therefore obtained
2 APs. At 1000 ms we set one maximal conductance parameter to zero,
knocking out this current from the cell. Intuitively, one would expect
such a protocol to give good information on the conductance of the cur-
rent that was blocked, since it directly shows the effect on the AP of re-
moving a particular ion current. The conductances we set to zero can
always be inferred with these protocols, and in many cases the alter-
ation in behaviour allows many additional conductances to be inferred
as well (see Supplementary Material Table B1 for the full results).
The last protocols that were tested were 1 Hz pacing for 10,000 ms
or 20,000 ms. These longer protocols allow slower time-scale dynamics
to reveal their effects, and therefore for information about the con-
ductances that govern these changes to be inferred more readilyy in models of the cardiac action potential: Can we build trustworthy
.11.018
Table 1
Number of conductance parameters that were constrained sufﬁciently given a particular model and simulated protocol. Our deﬁnition of success is thatMb0.05 for a parameter for the
length of theMCMC chain (having removed the ﬁrst quarter as a burn-in period). ‘n/a’ stands for ‘not applicable’, and indicates that themodels do not include the components necessary
to perform these protocols. N.B. Gto1 appears in [9], but Gto is in all other models in which the current is modelled.
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currents. Somewhat remarkably, the inference process was able to suc-
cessfully recover all 12 conductances in the ten Tusscher et al. [44]
model, 11/13 in the O'Hara et al. [34] model, and 12/14 in Davies et al.
[9] using just twenty 1 Hz APs. The two conductances in the O'Hara et
al. [34]modelwhichwere not successfully inferred from the 20 s protocol
are GbNa and GpCa, and in the Davies et al. [9] model GbCl and GpCa.Fig. 4. Subset of the histograms and pairwise probability distributions of each parameter using
rameters have been successfully inferred from the data, e.g. GbCa ,GbNa and PNaK. PNaK has the sha
vertical red (outside) lines give the 95% credible interval. The green (inside) lines are the para
Please cite this article as: R.H. Johnstone, et al., Uncertainty and variabilit
models?, J Mol Cell Cardiol (2015), http://dx.doi.org/10.1016/j.yjmcc.20152.2.2. Experimental data
As an example application of this technique we studied experimen-
tal canine action potentials gathered as described above in Section 2.1.2.
It is well known that there is substantial variability in action potentials
from beat-to-beat; but this behaviour is not very well understood and
could be due to stochastic channel opening [13], turnover/regulation
of ion channels, or chaotic dynamics [15].the ten Tusscher et al. (2004) model and single AP protocol for synthetic data. Not all pa-
pe of a typically converged distribution, but fails our test of success by being too wide. The
meter values used to generate the synthetic data.
y in models of the cardiac action potential: Can we build trustworthy
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8 R.H. Johnstone et al. / Journal of Molecular and Cellular Cardiology xxx (2015) xxx–xxxWe considered a recording from a single cardiomyocyte, and then
inferred possible conductances for a single pace (in the control set-
ting), allowing us to identify the majority of current densities for ca-
nine AP baseline to a high degree of accuracy (see Fig. 5). This
process was repeated for a train of subsequent action potentials to
uncover ionic currents that could be responsible for beat-to-beat
variability within a single cell. While we do not believe that a sudden
change of conductance values every second is a good model for the
emergence of beat-to-beat variability in a single cell, it may be ade-
quate to characterise the variability and generate a predictive
model for it.
Fig. 2 panels (D–F) show three experimentally recordedAPs (chosen
to span the range of behaviours we observed), together with the [9]Fig. 5. Posterior probability distribution estimates of current densities, and the noise parameter
consistent, e.g. GK1, others vary by a wide range, e.g. GKr, GKs. This ﬁgure should be considered
those currents for which we expect to be able to recover conductances using a single 1 Hz AP. T
time.
Please cite this article as: R.H. Johnstone, et al., Uncertainty and variabilit
models?, J Mol Cell Cardiol (2015), http://dx.doi.org/10.1016/j.yjmcc.2015model AP with its original parameters for reference, and also with con-
ductances adjusted to themaximum likelihood obtained of the inferred
distributions. In all cases the inferred conductances result in a very good
ﬁt to the experimental AP compared with the default parameters,
although some small differences are visible; for instance, the model
ﬁts all have a more pronounced change of gradient at the end of the ac-
tion potential plateau than the experimental traces, whichmay indicate
that the kinetics of the model's repolarisation currents need some
reﬁnement.
In Fig. 5 we present the conductances that were inferred for all
membrane currents. Note that we do not expect all conductances to
be ﬁtted with narrow distributions to a single AP, as there was insufﬁ-
cient information in the synthetic data situation to recover them allσ, inferred from a series of canine cardiomyocyte APs. While some currents are relatively
in the light of the results in Table 1 (and Supplementary Material Table B1), which shows
he colours transition from semi-transparent blue to semi-transparent green through
y in models of the cardiac action potential: Can we build trustworthy
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so we do not expect to recover background, pump or exchanger con-
ductances. These current densities are not directly accessible, and
this is a novel way to infer the contribution of each ion current to
the formation of the action potential and therefore normal cardiac
function.
There are currents for which large differences are evident in the dis-
tributions inferred for each pace, that were all recovered withMib0.25
in the synthetic data case. Observing distinct probability distributions
between paces suggests that those currents take different magnitudes
between different paces. For instance, GKs, GKr, GNa, GCaL and Gto1 all
show large variation in Fig. 5, and are likely to play a large role in gener-
ating beat-to-beat variability. Interestingly, these same currents were
identiﬁed as possible causes of beat-to-beat variability (also in a canine
myocyte simulation study) when the currents were replaced with sto-
chastic formulations ([18], see Fig. 2).
We also used the inferred conductances to predict the beat-to-beat
variability that would be observed after Moxiﬂoxacin addition and the
change in bath concentrations; full results are shown in Supplementary
Material B6. We predicted the correct trends in the data with an in-
creased beat-to-beat variability in APD after the intervention, although
the APDs themselves were generally shorter than those recorded
experimentally.Table 2
Range of conductances used to ﬁt the TP06 emulator with 25, 50 and 100 design points.
Input parameter Units Mean Range
GNa nS pF -1 14.838 7.42–22.26
GK1 nS pF -1 5.405 2.70–8.10
Gto nS pF -1 0.294 0.147–0.441
GKr nS pF -1 0.153 0.077–0.230
GKs nS pF -1 0.392 0.196–0.588
GCaL cm 3 ms -1 μF-1 0.0000398 0.0000199–0.0000597
τf multiplier dimensionless 1.0 0.50–1.50
GbNa nS pF -1 0.00029 0.000145–0.000435
GbCa nS pF -1 0.00059 0.000295–0.000885
GpCa nS pF -1 0.123 0.0615–0.1845
GpK nS pF -1 0.0146 0.0073–0.0219
PNaK pA pF -1 2.724 1.362–4.086
kNaCa pA pF -1 1000.0 500.0–1500.03. Case study 2: GP emulators for cardiac action potential models
The analysis described above demonstrates how model inputs and
parameters can be inferred as distributions, which embed uncertainty
about the parameter value. In our second case study, we show how un-
certainty in model parameters can be propagated through a cardiac AP
model, so that we can see the effect of parameter uncertainty on the
model output.
One approach to this question is to run the cardiac model many
times, and to select parameter values for each run from the parameter
distribution. Such Monte Carlo approaches require many model runs
(typically several thousand) to build up distributions of the model out-
put [7], and so in this case study we illustrate the use of statistical emu-
lators (metamodels or surrogate models) for UQ in cardiac AP models,
by building emulators of the ten Tusscher et al. (2006) model [45]
(TP06) of the human ventricular myocyte.
An emulator is a statistical model that estimates the output of a
computational model given a set of inputs. In our case themodel out-
puts are descriptors of AP shape obtained from the TP06 model, and
the inputs are the conductances of ion channels, pumps, and ex-
changers. An emulator approach therefore offers a way to explore
the behaviour of a model without the cost of running a computation-
ally expensive model many times. Emulators are trained using a set
of design data, which are inputs and outputs obtained from runs of
the computational model. The emulator can then be used as a fast-
running surrogate to estimate model output for any set of inputs.
The emulator also returns a variance function, which is a measure
of the emulator uncertainty, and for example will be zero at the de-
sign points, where the true model output is known. For a graphical
example of an emulator of a simple one-parameter model, see Sup-
plementary Material C1.
A Gaussian Process (GP) emulator can use Normal distributions to
represent both inputs and outputs, and so uncertainty is embedded
throughout. An enormously powerful feature of GP emulators is that
under certain assumptions, including that model inputs follow a multi-
variate Normal distribution, the corresponding distributions for model
outputs can be computed analytically (see Supplementary Material C1
for an illustration). Therefore, uncertainty propagation, as well as vari-
ance based sensitivity analysis (see below) can be calculated directly
from emulator properties—without repeated runs the of the emulator,
let alone the original model.Please cite this article as: R.H. Johnstone, et al., Uncertainty and variabilit
models?, J Mol Cell Cardiol (2015), http://dx.doi.org/10.1016/j.yjmcc.20153.1. Methods
Our approach to emulator construction was based on that described
in previous studies [32], [24] and used a mathematical tool kit devel-
oped for UQ in computer models (http://mucm.aston.ac.uk/toolkit/
index.php). For a detailed treatment of these techniques applied to a
cardiac action potential model we refer the reader to an earlier study
[7], and Supplementary Material C.
3.1.1. Implementation of the TP06 model
The TP06 model for epicardial cells was implemented in MatLab
(Mathworks), with code automatically generated from the Physiome
Repository (http://models.physiomeproject.org, [48]). The model was
conﬁgured to run for 20 beats at a cycle length of 1000ms using the ini-
tial conditions speciﬁed in CellML, andwas solved with theMatlab time
adaptive solver for stiff systems of ordinary differential equations
ode15s. Each beat was elicited with a stimulus of strength −52 pA
pF−1 applied for 1 ms. This protocol enabled the model to approach a
steady state, and in the multiple runs undertaken for the design data
(see below) the greatest absolute difference in APD between the 19th
and 20th beats was less than 0.5 ms.
3.1.2. Inputs and outputs
We selected as model inputs the 12 maximal conductances in the
TP06 model, along with a multiplier of the time constant for slow inac-
tivation of the L-type Ca2+ channel τf. The rationale for selecting these
parameters as inputs was that the maximal conductances provide a
clear link to cellular physiology as they represent the density of ion
channel proteins in the cell membrane. As outputs, we selected six de-
scriptors of AP shape based on membrane voltage (Vm) measurements
used in recent studies (e.g. [6]); maximum dVm/dt, maximum Vm,
dome Vm, APD90, resting Vm, and APD50. For the design and test data
(see below) these outputs were obtained from the 20th AP in each run.
3.1.3. Design data and emulator construction
We built separate emulators for each model output. The GP param-
eters for each emulator were determined by ﬁtting to design data, com-
prising a set of input parameters and corresponding model outputs
obtained from multiple runs of the model. For each model run, we se-
lected the input parameters using Latin hypercube sampling from uni-
form distributions centred on the input parameter value speciﬁed in
the original model, and with a range of half this value (see Table 2).
We chose this range so that the emulator could be trained over a region
of parameter space that was large enough to examine the effects of un-
certainty in the input parameters. For clarity and convenience, each of
these input parameter ranges were transformed into normalised units,
so that the minimum value of the input parameter became 0, the max-
imum became 1, and the central value 0.5.y in models of the cardiac action potential: Can we build trustworthy
.11.018
Fig. 6. TP06 design data for 50 model runs (coloured circles), and test data obtained from 10 additional model runs (grey circles).
10 R.H. Johnstone et al. / Journal of Molecular and Cellular Cardiology xxx (2015) xxx–xxxDesign data from 50 model runs are plotted in Fig. 6, some depen-
dencies are immediately clear. For example, GNa has a strong inﬂuence
on both maximum dVm/dt and maximum Vm, while GCaL has an inﬂu-
ence on dome Vm. Both of these dependencies might be expected
from knowledge of the physiology that the model represents. However
many of the other associations between inputs and outputs are unclear
from this ﬁgure, for example the model parameters that determine
APD90 are not easy to identify.
The number of simulator runs in the design data needed to pro-
duce a good emulator can be determined by measuring the quality
of the emulator ﬁt with different numbers of design data. Quality of
ﬁt can be assessed using a further set of model runs (test points),
where for each set of inputs the output of the emulator is compared
with the output of the model using a statistical test [2]. We built em-
ulators using design data from 25, 50, and 100 model runs, with an
additional 10 model runs to produce test data. After comparing em-
ulator outputs and test data outputs (see Supplementary Material
C3 for the details), we established that 50 design points were enough
model runs to obtain a satisfactory emulator ﬁt for the TP06 model
outputs, and these emulators were used for the results presented
below.
3.2. Results
3.2.1. Sensitivity analysis
Sensitivity analysis is a measure of how the output of a model
depends on its inputs. The GP emulators built in this study can be
used in two ways to assess how the model outputs depend on
parameters.
First we assessed the contribution of each input to each output in
mean effect plots, which show how the expectation of each output
changed as each input in turn was assigned a ﬁxed value that varied
across the range 0 to 1 in normalised units (see Table 2 for this range
in natural units), while the other inputs were assigned a ﬁxed mean of
0.5 and a ﬁxed variance of 0.04. We then calculated the main effectPlease cite this article as: R.H. Johnstone, et al., Uncertainty and variabilit
models?, J Mol Cell Cardiol (2015), http://dx.doi.org/10.1016/j.yjmcc.2015index, which for each input was the ratio of the variance in themean ef-
fect when that input was ﬁxed to 0.5 to the variance in the emulator
output when all inputs were assigned a mean of 0.5 and a variance of
0.04. This quantity can be interpreted as a sensitivity index, which is
the proportion of the total output variance that is accounted for by the
variance on each of the inputs.
The mean effects calculated directly from the Max. dVm/dt
and APD90 emulators constructed from 50 design points are shown in
Fig. 7(a) and (b) respectively. These plots show how the emulator out-
put changed when each of the inputs in turn was varied in the range
from 0 to 1 in normalised units (see Table 2 for these ranges in natural
units), while the other inputs were effectively held constant at 0.5 by
setting a variance of 0.04. When each parameter has a normalised
value of 0.5, the emulator output was the same as the model output
for the default parameter settings.
The overall pattern in these mean effects plots was consistent
with the representation of cellular electrophysiology in the TP06
model and the design data shown in Fig. 6. GNa was strongly linked
to Max. dVm/dt, whereas APD was inﬂuenced by the balance of K+
and Ca2+ currents during the AP plateau and repolarisation. This
observation conﬁrms that the emulators have captured what we
know about the model. However, these plots also quantify the ef-
fect of each parameter and so provide a quantitative mechanistic
insight into the model as well as the physiology that the model
represents.
The main effects sensitivity analysis generalises the results from
mean effects plots, and is shown in Fig. 8 for all of the inputs and
each of the emulators. This measure indicates the proportion of the
variance in each output (row) that can be attributed to variance in
the input (column), and each square is coloured to indicate the mag-
nitude of this index. As well as the links already shown in Fig. 7, these
sensitivity indices show that Max. Vm is sensitive to GNa, GCaL inﬂu-
ences Dome Vm, APD90 and APD50 are both inﬂuenced by a similar
group of inputs, and resting voltage is inﬂuenced by GK1 and pump
currents.y in models of the cardiac action potential: Can we build trustworthy
.11.018
Fig. 8.Main effect sensitivity indices for each TP06 emulator.
Fig. 7. (a, b)Mean effects plots for (a)Max. dVm/dt and (b) APD90 emulators, showing howvarying each input in the range from0 to 1 inﬂuences the expected value of the emulator output.
(c, d) Cumulative effect of changing the variance of inputs on emulator outputs. (c) Distributions of Max. dVm/dt when GNawas reduced from 0.04 (red), to 0.02 (blue), 0.01 (green), and
0.005 (yellow) while the variance of all other inputs wasmaintained at 0.04 normalised units. (d) Distributions of APD90 when the variance of all inputs was initially set to 0.001 normal-
ised units, and then the variance of GKr (red), GKs (blue), GCaL (green), and then τf multiplier (yellow) were set to 0.04 normalised units.
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To illustrate how a GP emulator can be used to examine uncertainty
propagation, we calculated distributions of Max. dVm/dt and APD90 di-
rectly from the emulators, in cases where the model inputs were
assigned different distributions. The details of these calculations are de-
scribed elsewhere [32], [7].
Fig. 7(c) shows the effect of reducing the variance of GNa on the dis-
tribution ofMax. dVm/dt. Initially, all of the inputswere assigned amean
of 0.5 and a variance of 0.04 in normalised units, so the mean of each
input corresponded to the value in natural units given in the third col-
umn of Table 2. The distribution of Max. dVm/dt for these initial inputs
is shown by the red line. The variance of GNawas then progressively re-
duced from 0.04, to 0.02, 0.01, and 0.005 in normalised units (0.60, 0.30,
0.15, and 0.075 nS pF−1), and the resulting distributions of Max. dVm/dt
are shown by the blue, green, and yellow lines respectively.
Reducing the variance ofGNa can be interpreted as learning the value
of GNa with greater conﬁdence, and so this ﬁgure shows how
uncertainty in the model output can be reduced by knowing the value
of an input more precisely, using the approaches described in case
study 1. However, the uncertainty in the output is only inﬂuenced by in-
puts to which the output is sensitive. Reducing the variance of GNa from
0.04 to 0.005 reduced the standard deviation of Max. dVm/dt from 25 to
10 mVms−1, whereas reducing the variance of PNaK from 0.04 to 0.001
had a minimal effect, reducing Max. dVm/dt by only 0.001 mV ms−1.
In Fig. 7(d), we show the results of a multivariate analysis where we
examine the effect of uncertainty in several inputs on uncertainty in
APD90. Initially, all inputs were assigned a mean of 0.5, and a very
small variance of 0.001. This conﬁguration yielded an output distribu-
tion of APD90 with a mean of 306.7 ms and a standard deviation of
2.6 ms, which can be interpreted as a situation where the model inputs
are known with conﬁdence.
Experimental data [45] indicate variability in measurements of APD,
and typically this variability is around 10 ms around the mean value. To
illustrate how an emulator could be used to investigate the possible
sources of variability in APD90, we increased the variance of some inputs
from 0.001 to 0.04 and calculated the resulting distributions of APD90.
Fig. 7(d) shows the effect of increasing the variance of GKr (red line),
GKr and GKs (blue line), GKr, GKs, and GCaL (green line), and GKr, GKs,
GCaL, and τf (yellow line).
This illustrative example shows how an emulator can be used to
identify the uncertainties in combinations of inputs that are consistent
with uncertainty observed in outputs.
It should be stressed that this rich information has been gained from
only 50 model runs for design data and 10 model runs for test data,
many fewer than would be needed for Monte Carlo analysis. In a previ-
ous study [7], equivalent distributions of APD90were calculated using an
emulator and a Monte Carlo approach. Whereas multiple distributions
could be calculated directly from the emulator trained on a single set
of design data, 2000model runs were required for each distribution cal-
culated using a Monte Carlo approach.
4. Discussion
Models of the cardiac action potential are powerful tools that have
provided mechanistic insight into complex biophysical systems. How-
ever, cardiac cells and tissue are adaptive and heterogeneous living sys-
tems, where there is variability in the shape and size of individual cells,
and also in the density of ion channels, pumps, and exchangers in the
cell membrane. Beat-to-beat ﬂuctuations in ion concentrations and ion
channel gating introduce further variability into the action potential. Al-
though the present generation of cardiac action potential models can
provide a mechanistic description of action potential generation, they
neither capture these types of variability, nor is it always easy to deter-
mine how the model outputs depend on the parameters.
In the case studies presentedhere,wehave shownhowmathematical,
statistical and computational techniques for uncertainty quantiﬁcationPlease cite this article as: R.H. Johnstone, et al., Uncertainty and variabilit
models?, J Mol Cell Cardiol (2015), http://dx.doi.org/10.1016/j.yjmcc.2015can be adapted for use in cardiac electrophysiology modelling. These
powerful techniques can be used to quantify uncertaintywhen ﬁtting pa-
rameters to data; and then to examine the consequences of this uncer-
tainty on model predictions, either by running a simulation many times
or by building a simpler statistical model (emulator) of a biophysical
model. UQ allows us to place conﬁdence on model predictions, and
hence is a ﬁrst step in allowing us to say how much trust we should
place in model predictions. A better understanding of uncertainty in car-
diac action potential models will yield new insights into the sources of
variability, its mechanism(s) and consequences, in real cardiac cells and
tissue.
To explore UQ applied to cardiac APmodels, we have presented two
case studies which illustrate some of the key aspects. We can gain an
understanding of the challenges faced by considering future extensions
of these studies.
Case Study 1 illustrated how conductances can be inferred, with un-
certainty, from AP recordings using a Markov Chain Monte Carlo
(MCMC) inference method. This method was initially tested using
synthetic data, and used to investigate the experimental protocols neces-
sary to identify conductances using a variety of cardiac APmodels. Impor-
tantly this study also demonstrated how a protocol may not provide
sufﬁcient information to constrain certain parameters; uncertainty prop-
agation should be used to ascertain whether this is a problem formaking
predictions in any given context. Themethod has important potential ap-
plications in model development and optimal experimental design.
We applied the method to real experimental AP recordings, where
we also examined possible causes of beat-to-beat variability. Parameter
distributions were inferred from each individual voltage trace for a
given pace. Plotting the distributions for a single parameter frommulti-
ple different AP traces together shows the beat-to-beat variability in
maximal ion channel conductances. This is a newmethod for investigat-
ing which currents underlie beat-to-beat variability, providing novel
insight into normal cardiac function. In particular, GKr has amongst the
widest spread of distinct probability distributions, suggesting that IKr
is one of the main currents responsible for beat-to-beat variability. The
variation in maximal ion current conductance represents the varying
number of active ion channels in the membrane throughout each
pace. The spread of distributions for GKr suggests that this number of ac-
tive channels could vary by up to a factor of 3. Similarly, the spread of
distributions for GNa suggests that the number of active sodium chan-
nels may vary by a factor of 1.5. Whether these ﬂuctuations are due to
stochastic opening of ion channels, or other regulation/kinetics operat-
ing over multiple paces, will require further investigation.
Case Study 2 demonstrates the power of Gaussian Process (GP)
emulators. Emulators (fast-running surrogates of computationally-
demanding models) in general, will be important for uncertainty propa-
gation and sensitivity analysis, since they enable exploration of how out-
puts depend on multiple possible parameter values. GP emulators are
especially powerful because under the assumption that input parame-
ters can be described by a (multivariate) Normal distribution, output dis-
tributions for uncertainty propagation and sensitivity analysis can be
computed directly. However, an important assumption of GP emulators
is that the output surface is smooth. The good ﬁt of the emulators in
this study, evidenced by the Mahanalobis distance (Supplementary Ma-
terial C3) indicates that for the TP06 model under steady pacing this is a
reasonable assumption. Emulators ofmodels withmore complex behav-
iours such as APD alternans at short cycle lengths, will therefore need to
be constructed carefully. In this case study input parameter uncertainty
was not estimated from data. In future work, full conductance-related
UQ could be performed by using the results of Case Study 1 as input dis-
tributions for the Case Study 2 emulator, although if these input distribu-
tions are not well-approximated as multivariate Normal distributions
then repeated sampling using the emulator would be required.
In Pathmanathan et al. [38], uncertainty due to natural variability in
steady-state INa inactivation was characterised, and the resultant effect
on outputs of an AP model containing the inactivation sub-modely in models of the cardiac action potential: Can we build trustworthy
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developing a better understanding of inter- vs. intra-animal variability
(as discussed in Supplementary Material A), and other sources of vari-
ability. Repeating this process for other sub-models of cardiac AP
models will require signiﬁcant experimental and modelling effort.
4.1. Other sources of uncertainty
In this article we have focused on uncertainties in ion channel and
action potential model parameters. When moving to larger spatial
scales, using mono/bi-domain partial differential equation models for
spatial as well as temporal movement of charge, a number of other
sources of uncertainty will be introduced. One of the major inﬂuences
at this scale is the spatial distribution of action potential and ion current
properties. For example, simulation study ﬁndings could be strongly in-
ﬂuenced by trans-mural, apex-base, and left–right changes in ion chan-
nel expression in the ventricular walls, as well as variations in these
properties throughout the septum, papillary muscles, atria and conduc-
tion system.
Some important work has begun on examining the inﬂuence of spa-
tial uncertainties, for example how different possible underlying pat-
terns of IKs expression inﬂuence T-wave morphology [21]. In another
recent example, a whole-heart simulation study found arrhythmias
were inducible under simulated application of 8 drugs associated with
clinical risk, but when changing the spatial distribution of action poten-
tial model properties, to remove a distinct population of ‘M cells’, ar-
rhythmias were no longer inducible for any compounds [35].
Other tissue-scale parameters that are associated with substantial
uncertainty include the degree and orientation of cell-to-cell coupling
throughout the heart. The impact of other cell types, blood vessel distri-
bution and ﬁne-scale geometry are usually ‘homogenised away’ in
modelling assumptions, but may also strongly inﬂuence ﬁndings [23],
[4], [5]. As tissue mechanics, blood ﬂow, and ﬂuid/solid interaction are
introduced into sophisticated electro-mechanical models, the uncer-
tainties that are involved will rapidly escalate.
Much remains to be done to establish the sensitivity of any conclu-
sions from tissue simulations to these uncertainties. The computational
challenge is substantial, and will require technologies such as the emu-
lator we introduced in this article to be applied to these problems. We
expect that uncertainty analyses will be particularly important in
terms of susceptibility to arrhythmias, which may inform clinical deci-
sions in the future.
4.1. Conclusions
Uncertainties in cardiac action potential models and their parame-
ters need to be carefully quantiﬁed, and that results from simulation
studies should be examined in a probabilistic framework to establish
the robustness of their predictions to uncertainties. Such uncertainty
quantiﬁcation is crucial to the development of robust, reliable and trust-
worthy electrophysiological models, since cardiac myocytes are associ-
ated with much observational uncertainty and natural variability, and
UQ allows these to be formally and rigorously integrated into the
models. While the statistical techniques applied in this paper are ad-
vanced, wewish to emphasise that in some cases the simplest approach
to UQ may be sufﬁcient (ﬁtting a distribution for a parameter to a
dataset, and then using repeated sampling to estimate the distribution
of a model output, see [10] for an example of this). In general, however,
a close collaboration between experimentalists, modellers and statisti-
cians (amongst others) will be required.
Rigorous uncertainty assessment will be crucial for safety in clinical
applications, but there are likely to be important beneﬁts for basic sci-
ence too. Formal UQ will improve our quantitative understanding of
the sources and characteristics of natural variability in physiological sys-
tems, together with quantitative understanding of the consequences of
such variability. Overall, UQ applied to cardiac action potential modelsPlease cite this article as: R.H. Johnstone, et al., Uncertainty and variabilit
models?, J Mol Cell Cardiol (2015), http://dx.doi.org/10.1016/j.yjmcc.2015will be tremendously important for developing trustworthy models
and will provide a means for developing deeper physiological under-
standing of variability.
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